-
CAY10499 for HSL–MGL Lipid Assay Design
2026-09-22
CAY10499 is an inhibitor of human hormone sensitive lipase with additional activity against MGL and FAAH. This article explains how to deploy it as a lipid metabolism assay reagent while interpreting lipid-dependent macrophage and tumor-microenvironment experiments without confusing lipase inhibition with ACLY targeting.
-
Standardized Whole-Blood Immunometabolism Assays
2026-09-22
Zhao and colleagues present a standardized ex vivo whole-blood stimulation protocol for testing how metabolic interventions reshape cytokine responses to immune stimuli. The workflow preserves the complexity of human blood while organizing stimulation, metabolic modulation, controls, and cytokine measurement for more reproducible cohort-scale immunometabolism studies.
-
2X HyperFusion High-Fidelity Master Mix Workflows
2026-09-21
Build cloning, CRISPR construct, and complex-template PCR workflows around accurate, blunt-ended amplification rather than routine Taq performance. This guide combines practical setup parameters, optimization logic, and troubleshooting for researchers who need reproducible DNA assembly and downstream sequence confidence.
-
8-Chloroadenosine: From RNA Control to NSCLC Insight
2026-09-21
A translational framework for using 8-Chloroadenosine to connect RNA synthesis, lncRNA–IL-6 biology, and NSCLC model validation without confusing global transcriptional perturbation with pathway-specific causality.
-
Metformin Hydrochloride in Fibrosis Research
2026-09-20
Metformin Hydrochloride connects metabolic signaling with a practical antifibrotic workflow, from AMPK assays to rabbit vocal fold injury models. This guide translates the reference study into reproducible preparation, dosing, readout, and troubleshooting decisions.
-
cgSHAPE-seq Maps SARS-CoV-2 RNA Chimera Binding Sites
2026-09-19
The reference study introduces cgSHAPE-seq, a sequencing method that identifies small-molecule binding sites on structured RNA at single-nucleotide resolution. Applied to the SARS-CoV-2 5′ untranslated region, the method guided optimization of RNA-degrading chimeras, including C64, which reduced viral replication in cell-based experiments.
-
Oltipraz: A Redox Lens on MASLD
2026-09-18
Oltipraz provides a defined Nrf2 pathway perturbation strategy for connecting phase II enzyme induction with autophagy, ferroptosis, and liver-injury assays. Building on recent MASLD findings, this article outlines a translational workflow, clarifies the evidence boundaries, and explains why a single-molecule reference can strengthen mechanistic interpretation without being mistaken for clinical proof.
-
Butylated Hydroxyanisole (BHA) Workflow Guide
2026-09-18
Butylated hydroxyanisole (BHA) supports controlled oxidative stress experiments, from cell-free biomolecule protection to ROS and apoptosis readouts. This guide distinguishes direct radical-scavenging effects from downstream cellular responses and provides practical dosing, storage, and troubleshooting strategies.
-
From CRC Subtypes to qPCR Biomarker Proof
2026-09-17
Feng et al. link bile acid metabolism with colorectal cancer immune dysfunction and prognosis. This thought-leadership article explains how translational teams can convert those computational findings into reproducible qPCR evidence using broad-coverage cDNA synthesis and genomic DNA control.
-
Vidarabine monohydrate: Assay Reliability Guide
2026-09-17
Learn how Vidarabine monohydrate (SKU C6377) can support controlled antiviral, viability, and proliferation workflows when solvent compatibility, cell health, and DNA replication endpoints must be separated. This scenario-based guide emphasizes reproducible preparation, evidence-based controls, and practical product-selection criteria.
-
TG003 Cdc2-like Kinase Inhibitor Workflows
2026-09-16
TG003 provides reversible control of Clk-dependent serine/arginine-rich protein phosphorylation for alternative splicing and exon-inclusion studies. This guide extends that use into a carefully controlled ovarian-cancer platinum-resistance workflow while emphasizing why TG003 should not be treated as a CLK2-specific probe.
-
NAT10–ac4C Regulation of Mouse Oocyte Maturation
2026-09-16
The reference study identifies NAT10-mediated N4-acetylcytidine (ac4C) as a post-transcriptional regulator of mouse oocyte maturation in vitro. NAT10 knockdown reduced ac4C and impaired first polar body extrusion, while transcriptome and RNA-pulldown analyses nominated TBL3 as a potential ac4C-associated protein.
-
Cell Senescence β-Galactosidase Staining Kit Workflow
2026-09-15
Turn senescence-associated β-galactosidase activity into a visible blue readout for cultured cells and frozen tissue sections. This workflow shows how to apply the assay to HPV-oncology studies, distinguish phenotype from mechanism, and troubleshoot common staining failures.
-
MDL 28170: A Calpain Inhibitor for Synaptic Injury
2026-09-15
MDL 28170 is a selective calpain inhibitor for dissecting protease-driven neuronal and cellular injury. This article translates recent BDNF/TrkB findings into assay-selection, controls, and interpretation strategies beyond conventional neuroprotection workflows.
-
Bile Acid Subtyping Reveals Immune Dysfunction in CRC
2026-09-14
Feng et al. used bile acid metabolism-related transcriptomic patterns to classify colorectal cancer into molecular subtypes associated with survival and immune-cell infiltration. The study prioritizes CLCA1, UGT2A3, and ZG16 as reproducible markers, while identifying CLCA1 as the clearest prognostic candidate and providing a framework for follow-up gene expression analysis.